Eli Lilly is rethinking plans to add a manufacturing line to a plant in Ireland following President Trump’s call on drugmakers to invest in the U.S.

It is a reversal of fortunes for a Pfizer plant in Australia. The U.S. drugmaker has decided to close the facility and lay off nearly 90 workers after…

A Merck KGaA plant in Goa, India, has run into labor issues over wages and is now having to take steps to avoid product shortages.

Dr. Reddy’s Laboratories said regulatory problems with its substitute supplier may keep it from getting to market this quarter with a generic of blockbuster…

New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

India’s Strides Shasun has decided to radically remake itself, focusing on a consumer formulations business it will call Strides Pharma and spinning or selling…

Dublin-base Alkermes intends to increase capacity and add nearly 100 jobs to the Ohio plant that manufactures its opioid abuse drug Vivitrol.

The FDA has caught an Italian drugmaker apparently manipulating testing data, reporting only passing tests even though original reports gave different results.

KBI Biopharma has picked up a plant in Texas from struggling Opexa Therapeutics, allowing the CDMO to move into clinical stage cell therapy production.

Supply Chain